Writing Group for the CKD Prognosis Consortium et al
A Head-to-Head Comparison A pivotal clinical trial that directly compared these two medications shifted the landscape
Sam July 23, 2026 This works I have used this product for 4.5 weeks and Im already seeing a difference
In the liver, GH affects glucose body function and boosts IGF-1 production
We get more concerned when symptoms: Persist (hours to days) or steadily worsen Recur in a predictable pattern (for example, nightly burning in the feet) Are associated with weakness, clumsiness, balance problems, or pain Are one-sided and sudden (particularly when paired with speech, vision, or facial changes) Occur alongside signs of dehydration or poor intake (lightheadedness, palpitations, very dark urine, inability to keep fluids down) Because Ozempic can significantly change appetite and digestion, it can indirectly create conditions that make paresthesia more likely, even if the medication isn't the primary culprit
Tirzepatide (brand names Mounjaro and Zepbound) resulted in a decrease in 10.1 percent of body weight at six months and semaglutide (brand names Ozempic, Wegovy, and Rybelsus) resulted in a decrease of 5.8 percent of body weight at six months, according to a 2024 study in JAMA Internal Medicine